Recent Press Releases

WuXi PharmaTech Completes Construction of New Materials Characterization Facility in St. Paul

SHANGHAI, May 12, 2014 -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United...

Tigermed and Frontage Laboratories Announce Strategic Investment to Strengthen Global Drug Development Service Capabilities

EXTON, Pa.--Hangzhou Tigermed Consulting Co., Ltd. (hereafter 'Tigermed'), a leading provider of outsourced clinical development services across China and Asia Pacific to the pharmaceutical...

ONYX COMPLETES API PROJECT WITH US DRUG DEVELOPER

UK-based contract research organisation Onyx Scientific has completed a development and API manufacturing project with US-based Neuronascent, Inc to support the company with its focus on neurologic...

AMRI Announces First Quarter 2014 Results

Contract Revenue Growth of 10% to $51.0 Million and Adjusted Diluted EPS of $0.16 Company Increases 2014 Adjusted EPS Guidance to $0.78 - $0.84 to Reflect Addition of Cedarburg Pharmaceuticals and...

Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product

Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product Oklahoma City, OK (May 6, 2014)-- Cytovance Biologics, Inc.,...

Avillion Announces Royalty Pharma Investment

Jim Reddoch, PhD, Royalty Pharma Executive Vice President for Research and Investments Joins Avillion Board LONDON (UK) and NEW YORK, NY (US), May 6, 2014 – Avillion LLP, a company focused on...

Huntingdon Life Sciences Acquires Harlan Laboratories

HUNTINGDON, England -- Huntingdon Life Sciences announced today that it has acquired Harlan Laboratories. The new company will have two operating divisions: Research Models and Services and Contract...

TrialNetworks Joins the DrugDev Family of Technology-Driven Solutions to Advance the Common Goal of Enabling More Efficient Clinical Trials

Audubon, PA and Newton, Mass. - May 5, 2014 - DrugDev, the industry's largest global network of active clinical trial doctors, today announced its acquisition of TrialNetworks. The award-winning...

WuXi PharmaTech Facilities for Late - and Commercial-Stage Analytical and Stability Testing and Clinical-Trial Materials Manufacturing Pass FDA Audit

SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today...

COVANCE LAUNCHES NEW BRAND: SOLUTIONS MADE REAL™

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD), the world's most comprehensive drug development company, today announced its new brand, Solutions Made RealTM. This brand strategy more effectively...

Covance Reports First Quarter Net Revenue Growth Of 6.9% To $620 Million, Pro Forma EPS Growth Of 20.1% To $0.90 And Adjusted Net Orders Of $710 Million

PRINCETON, N.J. -- Covance Inc. (NYSE: CVD) today reported results for its first quarter ended March 31, 2014. Net revenue was $620 million, representing 6.9% growth from the first quarter of 2013....

Charles River Laboratories Announces First-Quarter 2014 Results from Continuing Operations

– First-Quarter Sales of $299.4 Million – – First-Quarter GAAP Earnings per Share of $0.67 and Non-GAAP Earnings per Share of $0.82 – – Raises Sales and Non-GAAP EPS...

Quintiles Reports First Quarter 2014 Results

Over $1.0 billion of service revenues representing 8.4% growth; Integrated Healthcare Services segment grew service revenues by 6.0% in the quarter Net new business wins of $1.27 billion...

PAREXEL International Reports Third Quarter Fiscal Year 2014 Results

-- Company increases Fiscal Year 2014 revenue and EPS guidance -- 8.3% year-over-year growth in third quarter consolidated service revenue to $492.4 million -- Gross margin of 34.4%, up 300 basis...

ICON Reports First Quarter 2014

Quarter 1 net revenue increased 10% year on year to $350 million. Income from operations was $43.0 million or 12.3% of revenue. Earnings per share were 57 cents. Gross Business wins were $494...

EDASA Scientific Raises Funds for 5-Year Drug Discovery Program

EDASA Scientific LTD, a Medicinal Chemistry CRO is pleased to announce that in a joint effort with an American-based biotech, they successfully managed to raise government funds for a five-year drug...

Seattle-based Contract Research Organization ReachBio Unveils New Website, Rebrands as ReachBio Research Labs

SEATTLE, April 28, 2014 -- ReachBio LLC announced today that it is extending its trade name and will start doing business as ReachBio Research Labs, effective immediately. As part of this rebranding,...

Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV)

BEIJING -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development, manufacturing and commercialization of vaccines,...

Harlan Laboratories Announces Invenium Pharmacology as Agent for Southeast Asia, Australia and New Zealand

ITINGEN, Switzerland--Harlan Laboratories, Ltd., a privately held provider of general and specialty toxicology services, announces the appointment of Invenium Pharmacology as its exclusive agent for...

Medidata Reports Record First Quarter 2014 Results

Record revenues of $76.6 million, a 21% year-over-year increase Record subscription revenue of $63.8 million, a 26% year-over-year increase Record billings of $90 million, a 43% year-over-year...